Dr. Zagzag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 55th St
Brooklyn, NY 11220Phone+1 212-263-5687
Education & Training
NYU Grossman School of MedicineFellowship, Neuropathology, 1990 - 1992- NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 1988 - 1990
University of Paris VII Faculty of MedicineClass of 1982
Certifications & Licensure
NY State Medical License 1992 - 2026- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Concentration and Activity of Lapatinib in Vestibular Schwannomas Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- Deep learning-based classifier for carcinoma of unknown primary using methylation quantitative trait loci.Adam Walker, Camila S Fang, Chanel Schroff, Jonathan Serrano, Varshini Vasudevaraja
Journal of Neuropathology and Experimental Neurology. 2024-11-28 - T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant Astrocytomas.Matthew D Lee, Rajan Jain, Kristyn Galbraith, Anna Chen, Evan Lieberman
Clinical Cancer Research. 2024-08-15 - 1 citationsPrognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.Kristyn Galbraith, Mekka Garcia, Siyu Wei, Anna Chen, Chanel Schroff
Neuro-Oncology. 2024-06-03
Journal Articles
- Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from the Cancer Genome AtlasD Zagzag, M Snuderl, A S Chi, American Journal of Neuroradiology
- Cell Surface Notch Ligand DLL3 Is a Therapeutic Target in Isocitrate Dehydrogenase Mutant GliomaJohn G Golfinos, Daniel P Cahill, Erik P Sulman, David Zagzag, Clinical Cancer Research
Press Mentions
Dr. David Zagzag on the Cutting-Edge Research in Neurology InnovationMay 22nd, 2023- Dr. David Zagzag Discusses the Most Common Neurodegenerative Diseases Among AmericansJanuary 7th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
